Hairy Cell Leukemia in Adults

We provide ongoing, compassionate care and monitoring for people with hairy cell leukemia. This is a rare, slow-growing cancer of infection-fighting white blood cells. Our specialists use sophisticated tests to diagnose this chronic disease and create a personalized treatment plan to manage it. Our team of oncologists, nurses, physical therapists, psychologists, and social workers can help enhance your wellbeing throughout treatment and recovery.

Clinical Trials and Research Studies

Phase 3

AALL1731: A Phase 3 Trial Investigating Blinatumomab (IND# 117467 NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

Learn More

Phase 2

Open-label Multicenter Phase 2 Study Evaluating the Efficacy & Safety of Daratumumab in Pediatric & Young Adult Subjects =1 & =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Learn More

Phase 3

EA9161: A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Learn More

Phase 3

Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia

Learn More